JP2008517605A - メラノコルチン受容体結合性ミメティボディ、組成物、方法および用途 - Google Patents

メラノコルチン受容体結合性ミメティボディ、組成物、方法および用途 Download PDF

Info

Publication number
JP2008517605A
JP2008517605A JP2007538172A JP2007538172A JP2008517605A JP 2008517605 A JP2008517605 A JP 2008517605A JP 2007538172 A JP2007538172 A JP 2007538172A JP 2007538172 A JP2007538172 A JP 2007538172A JP 2008517605 A JP2008517605 A JP 2008517605A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
cell
mimetibody
melanocortin receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007538172A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008517605A5 (cg-RX-API-DMAC7.html
Inventor
カンニングハム,マーク
ストジヤノビツク−ススリツク,ベドラナ
オニール,カリン
フアン,チチ
ルオ,ジエフレイ
Original Assignee
セントカー・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セントカー・インコーポレーテツド filed Critical セントカー・インコーポレーテツド
Publication of JP2008517605A publication Critical patent/JP2008517605A/ja
Publication of JP2008517605A5 publication Critical patent/JP2008517605A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2007538172A 2004-10-25 2005-10-25 メラノコルチン受容体結合性ミメティボディ、組成物、方法および用途 Pending JP2008517605A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25
PCT/US2005/038431 WO2006047535A2 (en) 2004-10-25 2005-10-25 Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (2)

Publication Number Publication Date
JP2008517605A true JP2008517605A (ja) 2008-05-29
JP2008517605A5 JP2008517605A5 (cg-RX-API-DMAC7.html) 2008-11-20

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007538172A Pending JP2008517605A (ja) 2004-10-25 2005-10-25 メラノコルチン受容体結合性ミメティボディ、組成物、方法および用途

Country Status (28)

Country Link
US (1) US20060105951A1 (cg-RX-API-DMAC7.html)
EP (1) EP1812046B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008517605A (cg-RX-API-DMAC7.html)
KR (1) KR101255140B1 (cg-RX-API-DMAC7.html)
CN (1) CN101437540B (cg-RX-API-DMAC7.html)
AT (1) ATE501731T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005299440B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0518411A2 (cg-RX-API-DMAC7.html)
CA (1) CA2585287A1 (cg-RX-API-DMAC7.html)
CY (1) CY1111486T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005026970D1 (cg-RX-API-DMAC7.html)
DK (1) DK1812046T3 (cg-RX-API-DMAC7.html)
EA (1) EA200700944A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP077416A (cg-RX-API-DMAC7.html)
ES (1) ES2363023T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20110405T1 (cg-RX-API-DMAC7.html)
IL (1) IL182683A0 (cg-RX-API-DMAC7.html)
MA (1) MA28943B1 (cg-RX-API-DMAC7.html)
ME (1) ME01234B (cg-RX-API-DMAC7.html)
MX (1) MX2007004974A (cg-RX-API-DMAC7.html)
NO (1) NO20072499L (cg-RX-API-DMAC7.html)
PL (1) PL1812046T3 (cg-RX-API-DMAC7.html)
PT (1) PT1812046E (cg-RX-API-DMAC7.html)
RS (1) RS51789B (cg-RX-API-DMAC7.html)
SI (1) SI1812046T1 (cg-RX-API-DMAC7.html)
TN (1) TNSN07157A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006047535A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200704260B (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011501963A (ja) * 2007-10-30 2011-01-20 セントコア・オーソ・バイオテツク・インコーポレーテツド メラノコルチン受容体結合ミメティボディ、組成物、方法及び使用
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー/エス 抗体重鎖のc末端の修飾による補体依存性細胞傷害の調節

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
AR072072A1 (es) * 2008-06-09 2010-08-04 Palatin Technologies Inc Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
EP2300036B1 (en) 2008-06-09 2017-04-05 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
BRPI1009644B1 (pt) 2009-06-08 2022-02-08 Palatin Technologies, Inc Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
EP2504351A4 (en) 2009-11-23 2013-10-30 Palatin Technologies Inc MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDE
AU2010321738B2 (en) 2009-11-23 2016-07-14 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
WO2020177627A1 (zh) * 2019-03-02 2020-09-10 上海一宸医药科技有限公司 一种双特异抗体

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003520015A (ja) * 1998-12-09 2003-07-02 エレノア ルーズベルト インスティテュート 体重およびそれに関連する状態を調節する組成物および方法
WO2004002424A2 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
WO2004002417A2 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use
EP1750754A4 (en) * 2004-03-31 2010-09-22 Centocor Ortho Biotech Inc HUMAN GLP-1 MIMETIC BODIES, COMPOSITIONS, METHODS AND USES

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003520015A (ja) * 1998-12-09 2003-07-02 エレノア ルーズベルト インスティテュート 体重およびそれに関連する状態を調節する組成物および方法
WO2004002424A2 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
WO2004002417A2 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011501963A (ja) * 2007-10-30 2011-01-20 セントコア・オーソ・バイオテツク・インコーポレーテツド メラノコルチン受容体結合ミメティボディ、組成物、方法及び使用
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー/エス 抗体重鎖のc末端の修飾による補体依存性細胞傷害の調節

Also Published As

Publication number Publication date
WO2006047535A2 (en) 2006-05-04
ATE501731T1 (de) 2011-04-15
HK1106445A1 (en) 2008-03-14
EP1812046B1 (en) 2011-03-16
PT1812046E (pt) 2011-06-28
SI1812046T1 (sl) 2011-06-30
ZA200704260B (en) 2009-03-25
CA2585287A1 (en) 2006-05-04
US20060105951A1 (en) 2006-05-18
WO2006047535A3 (en) 2008-09-04
PL1812046T3 (pl) 2011-08-31
IL182683A0 (en) 2007-09-20
RS51789B (sr) 2011-12-31
BRPI0518411A2 (pt) 2008-11-18
KR101255140B1 (ko) 2013-04-22
EA200700944A1 (ru) 2008-04-28
CY1111486T1 (el) 2015-08-05
HRP20110405T1 (hr) 2011-06-30
AU2005299440B2 (en) 2011-12-15
DK1812046T3 (da) 2011-06-06
CN101437540B (zh) 2012-12-19
CN101437540A (zh) 2009-05-20
NO20072499L (no) 2007-07-16
ECSP077416A (es) 2007-05-30
MA28943B1 (fr) 2007-10-01
ME01234B (me) 2013-06-20
KR20070085416A (ko) 2007-08-27
DE602005026970D1 (de) 2011-04-28
EP1812046A2 (en) 2007-08-01
MX2007004974A (es) 2007-10-17
TNSN07157A1 (en) 2008-11-21
EP1812046A4 (en) 2009-11-11
ES2363023T3 (es) 2011-07-19
AU2005299440A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
EP2214690B1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
CN113038964B (zh) 超长效胰岛素-fc融合蛋白及使用方法
EP2507267B1 (en) Compositions and methods for increasing serum half-life of fc fusion proteins
CN107286248B (zh) 高糖基化人生长激素融合蛋白及其制备方法与用途
CN106604739A (zh) 包括胰岛素和glp‑1/胰高血糖素双重激动剂的用于治疗糖尿病的组合物
EP1812046B1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
CN110172103B (zh) GLP-1类似物-Fc融合蛋白及其制备方法和用途
KR20220157910A (ko) Gdf15 변이체 및 glp-1 수용체 작용제를 포함하는 병용 투여용 조성물
EP1792626B1 (en) Treatment of obesity with alpha-MSH mimetibodies
CN114685644A (zh) 一种人glp-1多肽变体及其应用
WO2023125881A1 (zh) Glp-1和gdf15的融合蛋白及其用途
HK1106445B (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
CA2704446A1 (en) Melanocortin receptor binding mimetibodies, compositions, methods and uses
WO2023025129A1 (zh) Gdf15融合蛋白及其用途
HK1045160A (en) Expression and export of anti-obesity proteins as fc fusion proteins
HK1182312B (en) Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules for use in treating obesity and obesity-related disorders

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081003

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081003

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110517

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110815

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110822

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110920

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110928

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111017

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111024

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120131